Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems

PURPOSE: The 21-gene recurrence score (RS) identifies patients with breast cancer who derive little benefit from chemotherapy; it may reduce unwarranted variability in the use of chemotherapy. We tested whether the use of RS seems to guide chemotherapy receipt across different cancer care settings....

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Oncol Pract
Κύριοι συγγραφείς: Afghahi, Anosheh, Mathur, Maya, Thompson, Caroline A., Mitani, Aya, Rigdon, Joseph, Desai, Manisha, Yu, Peter P., de Bruin, Monique A., Seto, Tina, Olson, Cliff, Kenkare, Pragati, Gomez, Scarlett L., Das, Amar K., Luft, Harold S., Sledge, George W., Sing, Amy P., Kurian, Allison W.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2016
Θέματα:
Original Contributions
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957259/
https://ncbi.nlm.nih.gov/pubmed/27221993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2015.009803
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια